IMC raises US$225,000 in convertible note financing
The note bears 8% interest and is convertible into common shares, with proceeds for general corporate purposes.
See the latest news and media coverage for IMC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical cannabis company
imcannabis.comLast updated
In short: IMC announced plans to divest European assets, secured multiple convertible note financings, and explored entry into the U.S. market.
The note bears 8% interest and is convertible into common shares, with proceeds for general corporate purposes.
The transaction is expected to reduce debt by CAD$10.5 million and streamline operations.
The statement registers over 17 million common shares issuable upon conversion of notes and warrants.
Revenue of $8.7 million, operating loss of $1.7 million, net loss of $2.5 million.
IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it...
"Q1 2025 is a clear inflection point for IMC," said Oren Shuster, Chief Executive Officer of IMC. "Achieving net profitability and an 87% improvement in...
TORONTO and GLIL YAM, Israel, Oct. 2, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical...
TORONTO and GLIL YAM, Israel, July 29, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical...
Track IMC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.